US Patent Issued on Dec. 9 for "Radioconjugates targeting CD33 in the treatment of sarcomas" (New Jersey, New York Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,274, issued on Dec. 9.

"Radioconjugates targeting CD33 in the treatment of sarcomas" was invented by Mary M. Chen (Hoboken, N.J.), Avinash Desai (Ringoes, N.J.), Dale L. Ludwig (Rockaway, N.J.) and Mark Berger (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for treating cancers and proliferative disorders, including solid tumor cancers and non-myeloid hematological malignancies, using radioconjugates targeting CD33, alone or in combination with one or more radioconjugates targeting other cancer-associated targets such as DRS, 5T4, HER2, HER3, and TROP2, antibody drug conjugates targeting these ...